Trinity Biotech Company Description
Trinity Biotech might not be able to fix your problem, but it can probably tell you what your problem is. The diagnostics company make both laboratory-based tests and point-of-care diagnostics, which are administered and read in the presence of the patient. Its clinical laboratory portfolio includes instruments and assays for diagnosing blood disorders (sold under the Trini brand); infectious diseases (including STDs, bacterial infections, and other conditions); and diabetes. In the point-of-care market, the company primarily sells its Unigold and Capillus tests for diagnosing HIV at testing centers, public health facilities, hospitals, and other locations. Trinity Biotech sells its wares in some 80 countries.
View the Comprehensive Company Description for Trinity Biotech
The Company Description provides a historical perspective of Trinity Biotech's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of Trinity Biotech's evolution in the marketplace.
